Home > Name List By 3 > 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S, 6R)-5-[(2S,4S,5S,6R)-4, 5-dihydroxy-6-methyloxan-2-yl]oxy...

CAS No 20830-75-5 , 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,
6R)-5-[(2S,4S,5S,6R)-4,
5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-
hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,
6,7,8,9,11,12,15,16,
17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

  • Name: 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,
    6R)-5-[(2S,4S,5S,6R)-4,
    5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-
    hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,
    6,7,8,9,11,12,15,16,
    17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
  • Synonyms: Lanoxin; CHEBI:4551; DSSTox_RID_76794; 20830-75-5;12beta-Hydroxydigitoxin; NCGC00090797-03; DSSTox_CID_2934;3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,
    6R)-5-[(2S,4S,5S,6R)-4,
    5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-
    hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,
    6,7,8,9,11,12,15,16,
    17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ST069334;
  • CAS Registry Number:
  • Transport: UN 3462 6
  • Density: 1.36 g/cm3
  • Refractive index: 12 ° (C=10, Pyridine)
  • Safety Statements: R25:Toxicifswallowed.;
  • Hazard Symbols: T:Toxic;
  • EINECS: 244-068-1
  • Molecular Weight: 780.93846
  • InchiKey: LTMHDMANZUZIPE-PUGKRICDSA-N
  • InChI: InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30
    (38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27
    (39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,
    23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,
    26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1
  • Risk Statements: S28:Aftercontactwithskin,washimmediatelywithplentyof...;S45:Incaseofaccidentofifyoufeelunwell,seekmedicaladviceimmediately(showthelabelwherepossible).;
  • Molecular Formula: C41H64O14
  • Molecular Structure:CAS No:20830-75-5 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,<br />6R)-5-[(2S,4S,5S,6R)-4,<br />5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-<br />hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,<br />6,7,8,9,11,12,15,16,<br />17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one

Related products

References of 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,
6R)-5-[(2S,4S,5S,6R)-4,
5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-
hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,
6,7,8,9,11,12,15,16,
17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
Title: Digoxin
CAS Registry Number: 20830-75-5
CAS Name: (3b,5b,12b)-3-[(O-2,6-Dideoxy-b-D-ribo-hexopyranosyl-(1?4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1?4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxycard-20(22)-enolide
Trademarks: Digacin (Beiersdorf-Lilly); Dilanacin (AWD); Eudigox (Simes); Lanicor (Roche); Lanoxin (GSK); Lanoxicaps (GSK); Lenoxin (GSK); Neo-Dioxanin (Boehringer, Ing.); Rougoxin (Rougier)
Molecular Formula: C41H64O14
Molecular Weight: 780.94
Percent Composition: C 63.06%, H 8.26%, O 28.68%
Literature References: Secondary glycoside from Digitalis lanata Ehrh., or D. orientalis Lam., Scrophulariaceae: S. Smith, J. Chem. Soc. 1930, 508; Stoll, The Cardiac Glycosides (London, 1937); M. M. Dhar et al., IN 62497 (1958 to Council Sci. Indust. Res.), C.A. 53, 653b (1959). See also ref under Digoxigenin. Acid hydrolysis of digoxin yields 1 mol digoxigenin + 3 mols digitoxose. The sugar residue is attached to the hydroxyl group at C-3 of the aglycon. Clinical pharmacokinetics: J. K. Aronson, Clin. Pharmacokinet. 5, 137 (1980). Comprehensive description: P. R. B. Foss, S. A. Benezra, Anal. Profiles Drug Subs. 9, 207-243 (1980).
Properties: Radially arranged, four- and five-sided triclinic plates from dil alcohol or dil pyridine, decomp 230-265°. [a]25Hg +13.4 to 13.8° (c = 10 in pyridine). uv max (ethanol): 220 nm (e 12800). Sol in dil alcohol, pyridine, or mixt of chloroform and alcohol. Almost insol in ether, acetone, ethyl acetate, chloroform, water. More sol in hot 80% alcohol than gitoxin.
Optical Rotation: [a]25Hg +13.4 to 13.8° (c = 10 in pyridine)
Absorption maximum: uv max (ethanol): 220 nm (e 12800)
 
Derivative Type: b-Methyldigoxin
CAS Registry Number: 30685-43-9
Synonyms: Medigoxin; metildigoxin; 4¢¢¢-O-methyldigoxin; 3b,12b,14b-trihydroxy-5b-card-20(22)-enolide-3-(4¢¢¢-O-methyltridigitoxoside)
Trademarks: Cardiolan (Tosi); Lanirapid (Roche); Lanitop (Roche)
Molecular Formula: C42H66O14
Molecular Weight: 794.97
Percent Composition: C 63.46%, H 8.37%, O 28.18%
Literature References: Obtained by the O-methylation of digoxin: F. Kaiser et al., ZA 6806079; eidem, US 3538078 (1969, 1970 both to Boehringer, Mann.). Pharmacology and toxicity studies: W. Schaumann, R. Wegerle, Arzneim.-Forsch. 21, 225 (1971); H. Czerwek et al., ibid. 231.
Properties: Crystals, mp 227-231°. LD50 in rats, mice (mg/kg): 4.8, 4.9 i.v.; 6.2, 4.8 i.p.; 8.3, 7.8 orally (Czerwek).
Melting point: mp 227-231°
Toxicity data: LD50 in rats, mice (mg/kg): 4.8, 4.9 i.v.; 6.2, 4.8 i.p.; 8.3, 7.8 orally (Czerwek)
 
Derivative Type: a-Acetyldigoxin
CAS Registry Number: 5511-98-8
Trademarks: Lanatilin (Wabosan); Sandolanid (Sandoz)
Molecular Formula: C43H66O15
Molecular Weight: 822.98
Percent Composition: C 62.75%, H 8.08%, O 29.16%
Properties: Obtained by enzymatic hydrolysis of digilanide. Prisms from methanol + chloroform, dec 225°. [a]D20 +18.9° (pyridine). Very sparingly sol in ethyl acetate.
Optical Rotation: [a]D20 +18.9° (pyridine)
 
Derivative Type: b-Acetyldigoxin
CAS Registry Number: 5355-48-6
Trademarks: Kardiamed (Medice); Longdigox (Trommsdorff); Novodigal (Beiersdorf-Lilly); Stillacor (Wolff)
Properties: Needles from alcohol + chloroform, dec 240°. [a]D20 +30.4° (c = 1.2 in alc). More sol in ethyl acetate than the a-form.
Optical Rotation: [a]D20 +30.4° (c = 1.2 in alc)
 
Therap-Cat: Cardiotonic.
Therap-Cat-Vet: Cardiotonic.
Keywords: Cardiotonic.